1-2 of 2
Keywords: T1b prostate cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Andreas Schwarte, Edith A. Boedefeld, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2021) 105 (5-6): 428–435.
https://doi.org/10.1159/000512893
Published Online: 29 January 2021
... outcomes for IPC patients, whereas discontinuation rates seem to be lower for IPC. Thus, IPC patients at low risk of progression may be good candidates for AS. HAROW study Active surveillance Incidental prostate cancer Health-service research T1a prostate cancer T1b prostate cancer © 2021 S...
View article titled, Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study
Open the PDF for Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study in another window
Journal Articles

Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Okyaz Eminaga, Sebastian Wille, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2015) 95 (2): 209–215.
https://doi.org/10.1159/000431024
Published Online: 30 May 2015
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Active surveillance Incidental prostate cancer Outcomes research T1a prostate cancer T1b prostate cancer Prostate cancer (PCa) is termed ‘incidental' if diagnosed...
View article titled, Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study
Open the PDF for Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study in another window